Versant Capital Management’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
Versant Capital Management's PRAX Position: Q3 2026 in Review
Versant Capital Management increased its Praxis Precision Medicines (PRAX) stake by 100% in Q3 2026, buying an estimated $662 and bringing the position to 4 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2689.
Versant Capital Management first reported a position in PRAX in Q1 2026 and has held it in 3 quarters since. 290 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Versant Capital Management held 4 shares of Praxis Precision Medicines worth $1.16K as of Q3 2026.
- Versant Capital Management bought 2 Praxis Precision Medicines shares in Q3 2026, an estimated $662.
- Praxis Precision Medicines made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2689 holding.
- Versant Capital Management first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 3 quarters since.
- 290 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.